ATE547409T1 - Verbessertes verfahren zur herstellung von letrozol und zwischenprodukten davon - Google Patents

Verbessertes verfahren zur herstellung von letrozol und zwischenprodukten davon

Info

Publication number
ATE547409T1
ATE547409T1 AT08702736T AT08702736T ATE547409T1 AT E547409 T1 ATE547409 T1 AT E547409T1 AT 08702736 T AT08702736 T AT 08702736T AT 08702736 T AT08702736 T AT 08702736T AT E547409 T1 ATE547409 T1 AT E547409T1
Authority
AT
Austria
Prior art keywords
letrozole
producing
improved method
intermediate products
formula
Prior art date
Application number
AT08702736T
Other languages
English (en)
Inventor
Vimal Shrawat
Jai Singh
Rajesh Nautiyal
Original Assignee
Fresenius Kabi Oncology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Oncology Ltd filed Critical Fresenius Kabi Oncology Ltd
Application granted granted Critical
Publication of ATE547409T1 publication Critical patent/ATE547409T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT08702736T 2007-11-28 2008-01-16 Verbessertes verfahren zur herstellung von letrozol und zwischenprodukten davon ATE547409T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2479DE2007 2007-11-28
PCT/IN2008/000024 WO2009069140A1 (en) 2007-11-28 2008-01-16 An improved process for preparation of letrozole and its intermediates

Publications (1)

Publication Number Publication Date
ATE547409T1 true ATE547409T1 (de) 2012-03-15

Family

ID=39651226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08702736T ATE547409T1 (de) 2007-11-28 2008-01-16 Verbessertes verfahren zur herstellung von letrozol und zwischenprodukten davon

Country Status (4)

Country Link
US (1) US8198460B2 (de)
EP (1) EP2212301B1 (de)
AT (1) ATE547409T1 (de)
WO (1) WO2009069140A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2809086A1 (en) 2010-08-27 2012-03-01 Generics (Uk) Limited Pure intermediate
HUE047666T2 (hu) 2015-12-18 2020-05-28 Basf Agro Bv Eljárás 2-[4-(4-Klórfenoxi)-2-(trifluormetil)fenil]-1-(1,2,4-triazol-1-il)-2-propanol elõállítására
AU2018329202B2 (en) 2017-09-11 2022-10-27 Atossa Therapeutics, Inc. Methods for making and using endoxifen

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352795A (en) * 1986-03-07 1994-10-04 Ciba-Geigy Corporation Alpha-heterocycle substituted tolunitriles
US4978672A (en) * 1986-03-07 1990-12-18 Ciba-Geigy Corporation Alpha-heterocyclc substituted tolunitriles
EP1594850A2 (de) * 2003-02-06 2005-11-16 Sun Pharmaceuticals Industries Ltd. Regiospezifisches verfahren zur herstellung von 4- [1- (4-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitril
WO2005047269A1 (en) 2003-11-14 2005-05-26 Natco Pharma Limited A method for the separation of the letrozole precursor 4-‘1-(1,2,4-triazolyl) methyl!benzonitrile from its 1,3,4-triazolyl isomer
US20050209294A1 (en) * 2004-03-17 2005-09-22 Wadhwa Lalit K Process for producing 4-(1H-1,2,4-triazol-1-ylmethyl)benzonitrile
US20070003358A1 (en) * 2005-06-30 2007-01-04 Zibra, Llc Hand-held painting tool with paint reservoir
US7705159B2 (en) * 2005-07-06 2010-04-27 Sicor, Inc. Process for the preparation of letrozole
GT200600397A (es) * 2005-09-07 2007-08-28 Formulas topicas conteniendo o-desmetil venlafaxina (odv) o sus sales
WO2007039912A1 (en) 2005-10-05 2007-04-12 Usv Limited A one pot process for the preparation of 4-[1-cyanophenyl)-1-(1,2,4-triazol-1-yl)methyl]benzonitrile
EP1945618A2 (de) * 2005-10-20 2008-07-23 Cadila Healthcare Ltd. Verfahren zur herstellung von letrozol
US7518236B2 (en) * 2005-10-26 2009-04-14 General Electric Company Power circuit package and fabrication method
US20070100149A1 (en) * 2005-11-02 2007-05-03 Palle Venkata Raghavendra A Process for preparing letrozole
US7538230B2 (en) * 2005-11-14 2009-05-26 Chemagis Ltd. Letrozole production process
US7465749B2 (en) * 2005-11-14 2008-12-16 Chemagis, Ltd. Letrozole purification process
WO2007074474A1 (en) 2005-12-27 2007-07-05 Dabur Pharma Limited Novel intermediates for preparation of letrozole
WO2007090464A1 (en) 2006-02-08 2007-08-16 Solmag S.P.A. Process for preparing letrozole
TR200806911T1 (tr) * 2006-03-17 2009-01-21 Cipla Limited 4-[1-(4-siyano fenil)-1-(1,2,4-triazol-1-il)metil] benzonitril ile 4[1-(1h-1,2,4-triazol-1-il)metilen benzonitril ara maddesinin sentezi.

Also Published As

Publication number Publication date
EP2212301B1 (de) 2012-02-29
US20100234617A1 (en) 2010-09-16
US8198460B2 (en) 2012-06-12
EP2212301A1 (de) 2010-08-04
WO2009069140A1 (en) 2009-06-04

Similar Documents

Publication Publication Date Title
NZ612119A (en) Use of sigma ligands in bone cancer pain
JO2894B1 (en) Salt and new amorphous images
EA201100094A1 (ru) Тиадиазолилоксифениламидины и их применение в качестве фунгицидов
ATE440833T1 (de) Antithrombotische diamide
PE20120911A1 (es) Derivados de prolina como inhibidores de catepsina
EA202091893A1 (ru) Новые кристаллические формы
NO20070368L (no) Virale polymeraseinhibitorer
NO20091626L (no) MGLUR5-modulatorer
MY162022A (en) Chemical compounds 637: pyridopyrimidinediones as pde4 inhibitors
BRPI0922457A2 (pt) forma polimórfica de ácido 1-(4-{1-[(e)-4-ciclo-hexil-3-trifluormetil-benziloxi-imino]-etil)-2-etil-benzil)-azetidino-3-carboxílico"
MY150280A (en) Process of preparing derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
CY1112520T1 (el) Βενζυλαμινες, μια διαδικασια για την παραγωγη τους και η χρηση τους ως αντι-φλεγμονωδεις παραγοντες
DE602008001725D1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus
ME00928B (me) Novi postupak za sintezu agomelatina
IN2012DN01273A (de)
MX2012005329A (es) Compuestos benzoimidazolicos y sus usos.
CY1117397T1 (el) Παραγωγα 3-ετεροαρουλαμινο-προπιονικου οξεος και χρηση τους ως φαρμακευτικα
CY1118844T1 (el) Υποκατεστημενα παραγωγα 3-ετεροαροϋλαμινο-προπιονικου οξεος και χρηση τους ως φαρμακευτικα
CO6361988A2 (es) Forma cristalina de un compuesto de 4-[2-(2-fluorofenoximetil)fenil]piperidina.
EA201990097A1 (ru) Промышленный способ получения карипразина
DE502004008871D1 (de) Antiandrogene pyrrolidine mit tumorhemmender wirksamkeit
ATE547409T1 (de) Verbessertes verfahren zur herstellung von letrozol und zwischenprodukten davon
WO2008087654A3 (en) PIPERIDINES AS INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE TYPE 1
CY1116739T1 (el) Μεθοδος συνθεσης και κρυσταλλικη μορφη του υδροχλωρικου 4-{3-[cis-εξαϋδροκυκλοπεντα[c]πυρρολ-2(1η)-υλ] προποξυ} βενζαμιδιου καθως και η συνδεομενη ελευθερη βαση και οι φαρμακευτικες συνθεσεις οι οποιες τις περιεχουν
DE502007003531D1 (de) Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten